Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:34.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    RHYNS syndrome was added as a related term in the study record. This improves indexing and discoverability without changing the study procedures.
    Difference
    0.1%
    Check dated 2026-04-02T14:47:15.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0; the previous v3.4.3 label was removed.
    Difference
    0.1%
    Check dated 2026-03-18T20:27:22.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:25:18.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.4.2, and older notices about government funding and operating status have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:44:52.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A new site-wide notice warns that information may not be up to date due to a lapse in government funding, with guidance to check cc.nih.gov and opm.gov for updates. The page revision also updates to Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T00:39:12.000Z thumbnail image

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.